SFX by Ex Libris Inc.

Title:	Stroke volume response during exercise measured by acetylene uptake and MRI
Source:	Physiological Measurement [0967-3334] Groepenhoff, Herman yr:2006

Basic

Full text

Full text available via Institute of Physics Historic Archive Purchase

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Postmus, P. "Impaired stroke volume response to exercise in pulmonary arterial hypertension." Journal of the American College of Cardiology 47.8 (2006): 1732-3.
description	2.	0, N. "Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology." European heart journal 25.24 (2004): 2243-2278.
description	3.	Dalen, James E E. "The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism." Archives of internal medicine 162.22 (2002): 2521-2523.
description	4.	Kuschner, Ware G G. "Sildenafil citrate therapy for pulmonary arterial hypertension." The New England journal of medicine 353.20 (2006): 1091-3.
description	5.	Simonneau, G. "Treatment of pulmonary arterial hypertension." New England Journal of Medicine, The 351.14 (2004): 1425-36.
description	6.	Ghofrani, Hossein A A. "Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension." Journal of the American College of Cardiology 43.12 Suppl S (2004): 68-72.
description	7.	Goldhaber, Samuel Z Z. "Acute pulmonary embolism: risk stratification." Pathophysiology of haemostasis and thrombosis 35.1-2 (2006): 153-6.
description	8.	BOONSTRA, A. "Interpreting an ERP-implementation project from a stakeholder perspective." International journal of project management 24.1 (2006): 38-52.
description	9.	Domanski, M J J. "Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction." Journal of the American College of Cardiology 33.4 (1999): 951-8.
description	10.	Lonsdorfer-Wolf, E. "Pulmonary hemodynamics during a strenuous intermittent exercise in healthy subjects." Medicine and science in sports and exercise 35.11 (2003): 1866-1874.
description	11.	Kuijpers, T J J. "Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system." Investigative radiology 30.2 (1995): 75-8.
description	12.	Sastry, B K S K. "Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study." Journal of the American College of Cardiology 43.7 (2004): 1149-53.
description	13.	Loscalzo, J. "Pulmonary arterial hypertension." New England Journal of Medicine, The 351.16 (2004): 1655-65.
description	14.	Gali, N. "Tadalafil therapy for pulmonary arterial hypertension." Circulation 119.22 (2009): 2894-903.
description	15.	Griffiths, Mark J D J. "Inhaled nitric oxide therapy in adults." The New England journal of medicine 353.25 (2006): 2683-95.
description	16.	Rubin, L J J. "Primary pulmonary hypertension." New England Journal of Medicine, The 336.2 (1996): 111-7.
description	17.	Calder, Kirsten K K. "The mortality of untreated pulmonary embolism in emergency department patients." Annals of emergency medicine 45.3 (2005): 302-10.
description	18.	Nauffal, D. "Early complications in patients with pulmonary embolism." Medicina clínica 127.1 (2006): 1-4.
description	19.	Chockalingam, A. "Efficacy and optimal dose of sildenafil in primary pulmonary hypertension." International journal of cardiology 99.1 (2005): 91-5.
description	20.	Wilkins, Martin R R. "Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study." American journal of respiratory and critical care medicine 171.11 (2005): 1292-7.